Subscribe To
PRFX / PRFX Stock: The $2.7 Million Reason PainReform Is Up 100% Today
PRFX News
By InvestorPlace
July 20, 2023
Why Is PainReform (PRFX) Stock Up 38% Today?
PainReform (NASDAQ: PRFX ) stock is rallying on Thursday after the pharmaceutical company regained compliance with Nasdaq listing requirements. Accor more_horizontal
By InvestorPlace
July 14, 2023
PRFX Stock: The $2.7 Million Reason PainReform Is Up 100% Today
In the world of biotech stocks, one company that's generating big buzz today is PainReform (NASDAQ: PRFX ). The Israeli clinical-stage pharmaceutical more_horizontal
By InvestorPlace
July 12, 2023
Why Is PainReform (PRFX) Stock Down 40% Today?
PainReform (NASDAQ: PRFX ) stock is falling on Wednesday after the company announced a concurrent registered direct offering and private placement. Th more_horizontal
By InvestorPlace
February 8, 2023
Why Is PainReform (PRFX) Stock Up 48% Today?
PainReform (NASDAQ: PRFX ) stock is rocketing higher on Wednesday following an update on its delisting ordeal. A press release confirms that the compa more_horizontal
By GlobeNewsWire
March 21, 2022
PainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th
TEL AVIV, Israel, March 21, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharma more_horizontal